Replies to post #191800 on Enzolytics Inc (ENZC)

[sspalmo]

If "big pharma funding" was available then the following should not have been an issue.

"I am aware that Plaintiffs are claiming in their Motion (D.I. 10, ¶17) that SAGA did not make
payment of the monthly extension fee that was due on August 23, 2023. This is not accurate.
Attached hereto as Exhibit A are records of the payment made by SAGA for the August 23,
2023 extension fee (which was made on October 2, 2023). As for the extension fees due on
September 23, 2023, October 23, 2023 and November 23, 2023, I have been working closely
with SAGA’s transfer agent, Continental Stock Transfer and Trust (“Continental”), regarding
the fees that have not been paid. All payments for extension fees are paid to Continental,
overseen by Continental and held in trust in an account at UBS Bank."

"Plaintiffs’ request for an injunction to delay the special shareholders’ meeting to extend the
deadline date has and will continue to cause SAGA to suffer detriment. As a result of the
restraining order, SAGA has been unable to raise funds from third-parties, which would
have been used to pay for the overdue extension fees. I myself have been in touch with
several potential investors who have rescinded their offers to loan money to SAGA, as a
direct result of the fact that the November 21, 2023 shareholder meeting was delayed."

https://www.courtlistener.com/docket/67985445/31/gld-partners-lp-v-sagaliam-acquisition-corp/

[wickw50]

Doinkin, Imo, all that we will require from big pharma after the completion of the SPAC is their distribution channels. Big pharma will require our IP, so I anticipate multiple licensing agreements with at least 10 different big companies. GLTA!